FDA Takes Aim at Unapproved Rx Cold Meds

The U.S. Food and Drug Administration is going after nearly 500 unapproved prescription cough, cold, and allergy drugs that shouldn't be on the market, the agency announced today. The products include brands such as Cardec, Lodrane, Organidin, and Pedia-Hist, and many have issues with excessive amounts of active ingredients or extended-release formulas that don't function properly, according to Deborah Autor, director of compliance at the Center for Drug Evaluation and Research. "We don't know...Full Story
Commenting on this article is closed.